GER 40 Trade LogGER40 Short Position (Discretionary)
Rationale :
- Overextension: The GER40 index appears significantly overextended without substantial fundamental support.
- Rising German Bond Yields: An increase in German government bond yields suggests a shift towards higher borrowing costs, potentially impacting equity valuations.
- MACD Divergence: A notable divergence between the MACD indicator and price action indicates a weakening bullish momentum, often preceding a trend reversal.
- CVD Divergence: Divergence in the Cumulative Volume Delta points to a disparity between buying and selling pressures, signaling a potential downturn.
Trade Details :
- Position: Short GER40 via market order
- Risk Management:
- Risk per Trade: 1% of trading capital
- Risk-Reward Ratio (RRR): 1:2
Note: This trade is discretionary and anticipates a sharp correction at market open. Despite the lack of a formal signal, the confluence of technical indicators and macroeconomic factors supports this decision.
Euronext
Target 126Following weekly chart.
There is a cup & handle target which can lead to 126,
Both of my 2 indicators bullish in weekly chart but both of them are in the edge of a reversal signal in monthly chart.
Since B Gates also invested, I think we're ready to go :)
TP 126.3
SL 83.4 - please stop weekly close.
UPDATE: Euronext hit the first Target price at 1,549It's been a shortish hold for this analysis.
The price broke above the CUp and Handle. The price was above the 20 and 200MA stating a High Probability Trade.
And just yesterday the bulls pushed it up to the first target at 1,549.
I think we will get a bit of consolidation around these levels, but another upside swing is very likely.
I'll let you know
EuroNext major potential Cup and Handle - Upside to come to 1549Cup and Handle has been forming since August 2023.
Actually, what has formed is a V Pattern. Now there is a break down which could be a consolidation pattern forming.
During this time, we could see a Handle pattern - to complete the Cup and Handle.
If we see a breach above the brim level, we could see HUGE upside to come.
7>21>200
Price>200
Target 1,549
Either I am feeling too optimistic with January Effect, or we're in for great upside this year.
Let's see.
Is Sanofi Undervalue by 22% ?I wanted to share an analysis I've conducted on Sanofi over the past five years using both comparable methods and a 2-Stage DCF approach. According to my findings, the market value appears to be at least 22% undervalued in comparison with its fair value. Moreover, considering the post-COVID effects on pharmaceutical companies, I believe Sanofi presents a compelling opportunity to purchase its stock with potentially lower risk.
I would be glad to share my detailed analysis for any one interested in more in debt explorations
Disclaimer:
This information is based on my personal analysis and is not to be considered financial advice. I am expressing my own views and opinions on the current market conditions and Sanofi's stock. Always conduct your own research and consider seeking advice from a qualified financial professional before making any investment decisions.
Target 4.5Following monthly chart.
Got a super long signal from one of my indicators.
TP 4.5 - (nearly 50% gain)
SL 2.77 - Please wait for monthy close to stop.